Hormonal contraceptive use in adolescence and cortical brain metrics: Insights from the ABCD Study

Poster No:

957 

Submission Type:

Abstract Submission 

Authors:

Carina Heller1, Elvisha Dhamala2, Katherine Bottenhorn3, Megan Herting3, Brain Bossé4, Jennifer De La Rosa5, Leslie Farland5, Alicia Allen5, Claudia Barth6, Nicole Petersen4

Institutions:

1University of Minnesota, Minneapolis, MN, 2Feinstein Institutes for Medical Research, Glen Oaks, NY, 3Keck School of Medicine of USC, Los Angeles, CA, 4UCLA, Los Angeles, CA, 5University of Arizona, Tucson, AZ, 6Diakonhjemmet Hospital, Oslo, Norway

First Author:

Carina Heller  
University of Minnesota
Minneapolis, MN

Co-Author(s):

Elvisha Dhamala  
Feinstein Institutes for Medical Research
Glen Oaks, NY
Katherine Bottenhorn, PhD  
Keck School of Medicine of USC
Los Angeles, CA
Megan Herting, PhD  
Keck School of Medicine of USC
Los Angeles, CA
Brain Bossé  
UCLA
Los Angeles, CA
Jennifer De La Rosa  
University of Arizona
Tucson, AZ
Leslie Farland  
University of Arizona
Tucson, AZ
Alicia Allen  
University of Arizona
Tucson, AZ
Claudia Barth  
Diakonhjemmet Hospital
Oslo, Norway
Nicole Petersen  
UCLA
Los Angeles, CA

Introduction:

Adolescence is a critical period in human development, marked by a dynamic cascade of changes in brain structure and function (1), driven by neuromaturational processes such as myelination and synaptic pruning which actively shape the brain (2). Pubertal increases in sex steroids, including estrogens, progesterone, and testosterone, play a key role in shaping neurodevelopmental trajectories crucial for cognitive and emotional maturation (3). During this time, 1 in 5 females initiate hormonal contraceptive (HC) use (4), primarily in the form of oral contraceptive pills (OCPs), for contraceptive or therapeutic reasons (5). HCs contain exogenous hormones (ethinyl estradiol and a progestin) that reduce endogenous progesterone (6) and estradiol (7) production. In adults, OCP use has been associated with cortical morphometric brain changes that include lower cortical thickness in regions of the salience and default-mode network (8). Despite widespread HC use and extensive safety testing (9), their impact on adolescent brain development remains largely unexplored.

Methods:

We analyzed cortical thickness, surface area, and volume in 1,234 female adolescents from the ABCD Study from the 4-year follow-up (HC+: n = 65; HC-: n = 1,169). Hormonal levels of estradiol, testosterone, and dehydroepiandrosterone (DHEA), a precursor to testosterone, were compared between HC+ and HC- users. Structural brain differences and associations between hormonal levels and brain measures were assessed.

Results:

Salivary levels of estradiol, testosterone, and DHEA were significantly lower in HC+ users, with testosterone showing the largest difference (T = 4.64, p = 0.000004). However, all three distributions overlapped considerably. Cortical thickness was significantly thinner in HC+ users in regions including the bilateral paracentral, superior frontal, medial orbitofrontal, and superior parietal, left precentral, posterior cingulate, lateral occipital, and inferior temporal gyri, as well as the right precuneus. After applying False Discovery Rate (FDR) correction (10) for multiple comparisons, only cortical thickness in the paracentral gyrus remained significantly thinner in HC+ participants than in HC- (left: pFDR = 0.0225; right: pFDR = 0.0137; Figure 1 Panel A). HC+ participants exhibited significantly less surface area only in the left postcentral gyrus, and smaller volumes in the bilateral precentral, postcentral, and paracentral gyri, as well as the left lingual gyrus relative to HC- participants. However, results no longer met the threshold of statistical significance after FDR correction. Total intracranial volume (TIV) did not differ between groups. Across all participants, levels of estradiol were negatively correlated with cortical thickness in the right precuneus and left precentral gyrus after adjusting for puberty stage and TIV (Figure 1 Panel B). Estradiol, testosterone, and DHEA levels were negatively correlated with volume in several regions, including the left pre- and postcentral gyri. Surface area of the left postcentral gyrus negatively correlated with levels of estradiol and DHEA. Correlations did not remain significant after applying FDR correction.
Supporting Image: OHBM_figure.jpg
   ·Figure 1
 

Conclusions:

This work contributes to a growing body of literature examining the impact of HCs on brain structure, specifically addressing adolescence as a critical period for neurodevelopment. Our study identifies HC-related differences in childhood cortical morphology and highlights the need for continued research in this area across adolescent development. By elucidating impacts of HC-related hormonal suppression on brain structure and function, or lack thereof, we can better understand the potential risks and benefits associated with HC use during this critical period of brain maturation. Such insights are essential for informing clinical practice and public health policies aimed at optimizing adolescent reproductive, brain, and mental health.

Lifespan Development:

Early life, Adolescence, Aging 1

Neuroanatomy, Physiology, Metabolism and Neurotransmission:

Cortical Anatomy and Brain Mapping 2

Novel Imaging Acquisition Methods:

Anatomical MRI

Keywords:

Cortex
Development
MRI
Open Data
Other - Hormonal contraceptives

1|2Indicates the priority used for review

Abstract Information

By submitting your proposal, you grant permission for the Organization for Human Brain Mapping (OHBM) to distribute your work in any format, including video, audio print and electronic text through OHBM OnDemand, social media channels, the OHBM website, or other electronic publications and media.

I accept

The Open Science Special Interest Group (OSSIG) is introducing a reproducibility challenge for OHBM 2025. This new initiative aims to enhance the reproducibility of scientific results and foster collaborations between labs. Teams will consist of a “source” party and a “reproducing” party, and will be evaluated on the success of their replication, the openness of the source work, and additional deliverables. Click here for more information. Propose your OHBM abstract(s) as source work for future OHBM meetings by selecting one of the following options:

I do not want to participate in the reproducibility challenge.

Please indicate below if your study was a "resting state" or "task-activation” study.

Other

Healthy subjects only or patients (note that patient studies may also involve healthy subjects):

Healthy subjects

Was this research conducted in the United States?

Yes

Are you Internal Review Board (IRB) certified? Please note: Failure to have IRB, if applicable will lead to automatic rejection of abstract.

Not applicable

Were any human subjects research approved by the relevant Institutional Review Board or ethics panel? NOTE: Any human subjects studies without IRB approval will be automatically rejected.

Not applicable

Were any animal research approved by the relevant IACUC or other animal research panel? NOTE: Any animal studies without IACUC approval will be automatically rejected.

No

Please indicate which methods were used in your research:

Structural MRI

For human MRI, what field strength scanner do you use?

3.0T

Which processing packages did you use for your study?

Free Surfer

Provide references using APA citation style.

(1) Arain, M., Haque, M., Johal, L., Mathur, P., Nel, W., Rais, A., Sandhu, R., & Sharma, S. (2013). Maturation of the adolescent brain. Neuropsychiatric Disease and Treatment, 9, 449.
(2) Kolb, B., & Gibb, R. (2011). Brain Plasticity and Behaviour in the Developing Brain. Journal of the Canadian Academy of Child and Adolescent Psychiatry, 20(4), 265.
(3) Blakemore, S. J. (2008). The social brain in adolescence. Nature Reviews Neuroscience, 9(4), 267–277.
(4) Abma, J. C., & Martinez, G. M. (2011). Sexual Activity and Contraceptive Use Among Teenagers in the United States, 2011-2015.
(5) Armstrong C. (2010). ACOG Guidelines on Noncontraceptive Uses of Hormonal Contraceptives. American Family Physician, 82(3), 288–295.
(6) Thorneycroft, I. H., & Stone, S. C. (1972). Radioimmunoassay of serum progesterone in women receiving oral contraceptive steroids. Contraception, 5(2), 129–146.
(7) Sullivan, H., Furniss, H., Spona, J., & Elstein, M. (1999). Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activity. Fertility and Sterility, 72(1), 115–120.
(8) Heller, C., Kimmig, A. S., Kubicki, M. R., Derntl, B., & Kikinis, Z. (2022). Imaging the human brain on oral contraceptives : A review of structural imaging methods and implications for future research goals. Frontiers in Neuroendocrinology, 67(March), 101031.
(9) United Nations. (2019). Contraceptive Use by Method 2019. Contraceptive Use by Method 2019.
(10) Benjamini, Y., & Hochberg, Y. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. In Journal of the Royal Statistical Society. Series B (Methodological) (Vol. 57, pp. 289–300). WileyRoyal Statistical Society.

UNESCO Institute of Statistics and World Bank Waiver Form

I attest that I currently live, work, or study in a country on the UNESCO Institute of Statistics and World Bank List of Low and Middle Income Countries list provided.

No